• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4663739)   Today's Articles (0)   Subscriber (51598)
Download
Number Citation Analysis
1
Güren AK, Kocaaslan E, Ağyol Y, Majidova N, Sever N, Erel P, Çelebi A, Arikan R, Işik S, Sari M, Bayoğlu İV, Köstek O. HER2 exon 20 mutant non-small cell lung cancer with complete remission of intracranial metastases with trastuzumab deruxtecan: a case report. Anticancer Drugs 2024;35:769-773. [PMID: 39115060 DOI: 10.1097/cad.0000000000001625] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/18/2024]
2
Imre E, Gunhan HG, Erel P, Ustay O. SGLT2 inhibitors improve plasma atherogenic biomarkers in patients with type 2 diabetes: a real-world retrospective observational study. Minerva Endocrinol (Torino) 2023;48:295-304. [PMID: 33979071 DOI: 10.23736/s2724-6507.21.03465-5] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
3
Gunhan H, Imre E, Erel P, Ustay O. EMPAGLIFLOZIN IS MORE EFFECTIVE IN REDUCING MICROALBUMINURIA AND ALT LEVELS COMPARED WITH DAPAGLIFLOZIN: REAL LIFE EXPERIENCE. ACTA ENDOCRINOLOGICA (BUCHAREST, ROMANIA : 2005) 2020;16:59-67. [PMID: 32685040 PMCID: PMC7364004 DOI: 10.4183/aeb.2020.59] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Excel